HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Serial IMP-SPECT and EEG studies in an infant with hemimegalencephaly.

Abstract
An 8-month-old girl of hypomelanosis of Ito associated with hemimegalencephaly had frequent seizures beginning 44 h after birth. The seizures were secondarily generalized or unilateral initially, followed by infantile spasms at about 1.5 months of age. Frequent partial seizures appeared at 4 months of age. [123I]N-Isopropyl-p-iodoamphetamine (IMP) single photon emission computed tomography (SPECT) was performed serially during an interictal period at 1, 3 and 7 months of age. At 1 and 3 months, IMP-SPECT showed a marked increase of IMP uptake in the pathological left hemisphere and electroencephalography (EEG) revealed left-sided dominant hypsarrhythmia. At 7 months of age, a reversal was seen, there being decreased uptake on SPECT in the pathological hemisphere and abundant high amplitude background activity mingled with epileptic discharges on EEG in the non-pathological hemisphere. These serial changes of IMP uptake on SPECT seemed to reflect either changes in epileptic activity or maturational changes in cerebral perfusion in hemimegalencephaly.
AuthorsT Tagawa, K Otani, Y Futagi, A Wakayama, K Morimoto, Y Morita
JournalBrain & development (Brain Dev) 1994 Nov-Dec Vol. 16 Issue 6 Pg. 475-9 ISSN: 0387-7604 [Print] Netherlands
PMID7694999 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Amphetamines
  • Iodine Radioisotopes
  • Iofetamine
Topics
  • Age Factors
  • Amphetamines
  • Brain (abnormalities, diagnostic imaging, physiopathology)
  • Electroencephalography
  • Epilepsy (diagnosis, diagnostic imaging)
  • Female
  • Humans
  • Infant
  • Iodine Radioisotopes
  • Iofetamine
  • Tomography, Emission-Computed, Single-Photon

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: